gamma-Glutamylcysteine

Dipeptide (γ‑glutamylcysteine)Rx: OtcCompound: Research

Also known as: gamma-L-glutamyl-L-cysteine, GGC, L-gamma-glutamyl-L-cysteine, γ-GC, γ-glutamylcysteine, γ‑GC, γ‑Glutamylcysteine

Educational Only — Not medical advice. Consult a qualified clinician before using any peptide.

Source gamma-Glutamylcysteine at Peptiology

Save 10% with code PEPTI-BOSSRABBIT-10

Shop Now & Save 10% →

Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.

Summary

γ‑Glutamylcysteine is a naturally occurring dipeptide that is the rate‑limiting substrate for glutathione synthetase, boosting intracellular glutathione levels and supporting antioxidant capacity.

Mechanism of Action

serves as the immediate precursor for glutathione synthesis; provides cysteine for antioxidant defense

Routes of Administration

IntravenousOralTopical

Goals & Uses

  • increase glutathioneAntioxidant SupportModerate
  • Oxidative stress reductionAntioxidantModerate
  • Glutathione replenishmentAntioxidant / CytoprotectionModerate
  • NeuroprotectionNeurologyLow
  • HepatoprotectionCytoprotectionLow
  • Skin anti-aging / brighteningCosmetic / DermatologyLow

Contraindications

  • Known hypersensitivity to γ-GC or structurally related compoundsAllergyHigh
  • Cystinuria or cystine stone diseaseMetabolic DisorderModerate
  • cystinuriaMetabolic DisorderModerate

Adverse Effects

  • Injection site irritationLocal ReactionUncommon
  • Gastrointestinal upsetGastrointestinalCommon
  • Theoretical pro-oxidant effects at supraphysiologic dosesOxidativeUnknown
  • Sulfur-related gastrointestinal discomfortGastrointestinalUncommon

Drug Interactions

  • Cisplatin / alkylating chemotherapeuticsModerate
  • Buthionine sulfoximine (BSO)Moderate
  • N‑acetylcysteineLow

Population Constraints

  • PregnancyReproductive SafetyRelative
  • Renal impairmentOrgan ImpairmentRelative
  • Pediatric populationAgeRelative
  • Pregnant womenReproductiveRelative

Regulatory Status

  • European UnionUnapprovedmarketed as food supplement under novel food regulations
  • United StatesUnapprovedavailable as dietary supplement, not an FDA‑approved drug
  • United KingdomUnapprovedNot approved by MHRA as a medicinal product.

Not approved as a drug by FDA, EMA, or MHRA. Available as a research chemical and appears in some dietary supplement formulations. No IND or NDA on record as a standalone therapeutic.

Evidence & Sources

No sources recorded yet.

Frequently Asked Questions

What is gamma-Glutamylcysteine?

γ‑Glutamylcysteine is a naturally occurring dipeptide that is the rate‑limiting substrate for glutathione synthetase, boosting intracellular glutathione levels and supporting antioxidant capacity.

What is gamma-Glutamylcysteine used for?

gamma-Glutamylcysteine is educationally associated with: increase glutathione, Oxidative stress reduction, Glutathione replenishment, Neuroprotection, Hepatoprotection, Skin anti-aging / brightening. Educational only — not medical advice.

How is gamma-Glutamylcysteine administered?

Recorded routes of administration: Intravenous, Oral, Topical.

What are the potential side effects of gamma-Glutamylcysteine?

Reported adverse effects include: Injection site irritation, Gastrointestinal upset, Theoretical pro-oxidant effects at supraphysiologic doses, Sulfur-related gastrointestinal discomfort. This list is not exhaustive — consult a qualified clinician.

Who should avoid gamma-Glutamylcysteine?

Recorded contraindications: Known hypersensitivity to γ-GC or structurally related compounds, Cystinuria or cystine stone disease, cystinuria. Consult a qualified clinician before use.